Source link : https://tech365.info/stanford-is-operating-37000-ai-brokers-as-a-digital-biotech-and-one-in-all-its-drug-designs-acquired-independently-confirmed-by-merck/
For builders, the working assumption has been one engineer, one agent — the mannequin Claude Code and comparable instruments. At VB Rework 2026, James Zou, affiliate professor of biomedical knowledge science at Stanford College, argued that assumption is about to interrupt: the following frontier isn’t a single, extra succesful agent, it’s tens of 1000’s of them collaborating.
For builders and product builders, probably the most essential takeaway from Zou’s presentation is how these huge programs are orchestrated. His workforce’s analysis gives a sensible blueprint for connecting legacy databases to AI orchestration layers and designing environments that allow 1000’s of brokers to collaborate.
Emulating the group — the digital biotech
Zou’s challenge started as a “Virtual Lab” consisting of 5 to eight brokers structured to reflect his bodily Stanford lab. The setup included an AI professor performing because the principal investigator and AI college students with distinct specialties holding common group conferences.
“We also created for the agents a replica of Stanford, an agent school, where the agents can actually go to the school and do supervised fine-tuning to improve their expertise in their specific domains,” Zou famous.
The digital lab efficiently designed new nanobody proteins for current COVID variants.
“What is really exciting to us is that these AI-designed nanobody proteins actually worked much better than the previous human-designed…
—-
Author : tech365
Publish date : 2026-08-07 18:11:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8